The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Chronic Administration of Docosahexaenoic Acid Ameliorates the Impairment of Spatial Cognition Learning Ability in Amyloid β–Infused Rats
Open accessAbstract
We investigated whether administration of docosahexaenoic acid (DHA), a major (n-3) fatty acid of the brain, ameliorates the impairment of learning ability in an animal model of Alzheimer's disease (AD), rats infused with amyloid-beta (Abeta) peptide (1-40) into the cerebral ventricle. Inbred 3rd generation male rats (20 wk old) fed a fish oil-deficient diet were randomly divided into 4 groups: a vehicle group, an Abeta peptide-infused group (Abeta group), a DHA group, and an Abeta + DHA group. A mini-osmotic pump filled with Abeta peptide or vehicle was implanted in the rats, and they were tested for learning ability-related reference and working memory in an 8-arm radial maze. The rats were then orally fed DHA dissolved in 5% gum Arabic solution at 300 mg/(kg . d) (DHA and Abeta + DHA groups) or vehicle alone (vehicle and Abeta groups) and tested again for learning ability. DHA administered for 12 wk significantly reduced the increase in the number of reference and working memory errors in the Abeta-infused rats, and increased both the cortico-hippocampal level of DHA and the molar ratio of DHA/arachidonic acid, suggesting an amelioration of the impaired spatial cognition learning ability. Furthermore, DHA suppressed the increases in the levels of lipid peroxide and reactive oxygen species in the cerebral cortex and the hippocampus of Abeta-infused rats, suggesting that DHA increases antioxidative defenses. DHA is thus a possible therapeutic agent for ameliorating learning deficiencies due to Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DHA attenuates lipid peroxides and reactive oxygen species in the cerebral cortex and the hippocampus of Aβ-infused rats, suggesting that DHA elicits neuroprotection by blocking Aβ40/Aβ42 neurotoxicity (Calon et al., 2004; Hashimoto et al., 2005)”
From Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection (2018) · cites this paper as Hashimoto et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Direct transesterification of all classes of lipids in a one-step reaction.
Lepage, G., & ROY, C. C. (1986) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38861-1 · Cited by 2,385
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Neuringer, M. D., CONNOR, W. E., Lin, D. S., Barstad, L., & Luck, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4021 · Cited by 914
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667
Essential Fatty Acids and the Brain
Haag, M. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800308 · Cited by 421
Yamamoto, N., Saitoh, M., Moriuchi, A., Nomura, M., & Okuyama, H. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38713-7 · Cited by 383
Hashimoto, M., Hossain, S., Shimada, T., Sugioka, K., Yamasaki, H., Fujii, Y., Ishibashi, Y., Oka, J., & Shido, O. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00905.x · Cited by 364
Kitajka, K., Puskás, L. G., Zvara, Á., Hackler, L., Barceló‐Coblijn, G., Yeo, Y. K., & Farkas, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042698699 · Cited by 328
Gamoh, S., Hashimoto, M., Sugioka, K., Hossain, S., Hata, N., Misawa, Y., & Masumura, S. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00107-4 · Cited by 307
Molecular genetics of Alzheimer’s disease
George‐Hyslop, P. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00301-7 · Cited by 281
Yamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., & Nabeshima, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00408.x · Cited by 238
Stéphan, A., Laroche, S., & Davis, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05703.2001 · Cited by 228
McGahon, B., Martin, D. S. D., Horrobin, D. F., & Lynch, M. A. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00219-5 · Cited by 225
Gamoh, S., Hashimoto, M., Hossain, S., & Masumura, S. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03437.x · Cited by 213
Puskás, L. G., Kitajka, K., Nyakas, C. J., Barceló‐Coblijn, G., & Farkas, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337683100 · Cited by 176
Barceló‐Coblijn, G., Hőgyes, E., Kitajka, K., Puskás, L. G., Zvara, Á., Hackler, L., Nyakas, C. J., Penke, Z., & Farkas, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734008100 · Cited by 166
Nitta, A., Fukuta, T., Hasegawa, T., & Nabeshima, T. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.73.51 · Cited by 142
Minami, M., Kimura, S., Endo, T., Hamaue, N., Hirafuji, M., Togashi, H., Matsumoto, M., Yoshioka, M., Saito, H., Watanabe, S., et al. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00300-6 · Cited by 140
Eckert, G. P., Cairns, N. J., Maras, A., Gattaz, W. F., & Müller, W. E. G. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017234 · Cited by 137
Hossain, S., Hashimoto, M., Gamoh, S., & Masumura, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721133.x · Cited by 134
Jones, C. R., Arai, T., & Rapoport, S. I. (1997) · Neurochemical Research · doi:10.1023/a:1027341707837 · Cited by 119
Yatin, S. M., Aksenov, M. Y., & Butterfield, D. A. (1999) · Neurochemical Research · doi:10.1023/a:1020997903147 · Cited by 112
Winterfeld, K. T., Teuchert, G., & Dawirs, R. R. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980415)52:2 · Cited by 110
Fujita, S., Ikegaya, Y., Nishikawa, M., Nishiyama, N., & Matsuki, N. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703970 · Cited by 109
DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus
Favrelière, S., Perault, M. C., Huguet, F., de Javel, D., Bertrand, N., Piriou, A., & Durand, G. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00064-7 · Cited by 107
Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., & Hirayama, T. (1999) · Lipids · doi:10.1007/bf02562338 · Cited by 105
Okada, M., Amamoto, T., Tomonaga, M., Kawachi, A., Yazawa, K., Mine, K., & Fujiwara, M. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00427-0 · Cited by 101
Urano, S., Asai, Y., Makabe, S., Matsuo, M., Izumiyama, N., OHTSUBO, K., & Endō, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00064.x · Cited by 96
Hashimoto, M., Shinozuka, K., Gamoh, S., Tanabe, Y., Hossain, S., Kwon, Y. M., Hata, N., Misawa, Y., Kunitomo, M., & Masumura, S. (1999) · Journal of Nutrition · doi:10.1093/jn/129.1.70 · Cited by 91
Yamaguchi, H., Maat–Schieman, M. L. C., van Duinen, S. G., Prins, F. A., Neeskens, P., Natté, R., & Roos, R. A. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.723 · Cited by 91
Buczyński, A., Wachowicz, B., Kędziora–Kornatowska, K., Tkaczewski, W., & Kȩdziora, J. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90208-c · Cited by 87
Abeywardena, M. Y., McLennan, P. L., & Charnock, J. S. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.2.h379 · Cited by 71
Favrelière, S., Barrier, L., Durand, G., Chalon, S., & Tallineau, C. (1998) · Lipids · doi:10.1007/s11745-998-0221-y · Cited by 67
Hossain, S., Hashimoto, M., & Masumura, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00147-5 · Cited by 65
Docosahexaenoic acid–A new therapeutic approach to peroxisomal‐disorder patients
Martínez, M., Pineda, M., Vidal, R., Conill, J., & Martin, B. (1993) · Neurology · doi:10.1212/wnl.43.7.1389 · Cited by 64
Hashimoto, M., Hossain, S., Shimada, T., Yamasaki, H., Fujii, Y., & Shido, O. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31607-2 · Cited by 56
Fish Consumption and the Risk of Alzheimer Disease
Friedland, R. P. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.923 · Cited by 53
Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis
Kishida, E., Yano, M., Kasahara, M., & Masuzawa, Y. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00015-0 · Cited by 49
Effect of DHA Oil Supplementation on Intelligence and Visual Acuity in the Elderly
Suzuki, H., Morikawa, Y., & Takahashi, H. (2000) · KARGER eBooks · doi:10.1159/000059767 · Cited by 46
Nitta, A., Fukuta, T., Hasegawa, T., & Nabeshima, T. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.60.51 · Cited by 40
Shahdat, H., Hashimoto, M., Shimada, T., & Shido, O. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.028 · Cited by 25
Research works printed but not linked: 3
- Miyanaga, 1995, Clinical effects of DHA in demented patients, J. Clin. Ther. Med., 11, 881
- Kotchabhakdi, 2003, Effects of different dosages of docosahexaenoic acid (DHA) intake on maze-learning ability and dendritic spines in rats, Soc. Neurosci. Abstracts Program No. 941.17.
- Lim, 2003, Diets enriched with polyunsaturated DHA (docosahexaenoic acid) can lower amyloid levels and plaque burden in an Alzheimer’s disease mouse model, Soc. Neurosci. Abstracts Program No. 201.25.
Cited by
Sorted by citations
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372
Lukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 897
Essential Fatty Acids: Biochemistry, Physiology and Pathology
Das, U. N. (2006) · Biotechnology Journal · doi:10.1002/biot.200600012 · Cited by 650
Barceló‐Coblijn, G., & Murphy, E. J. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.07.002 · Cited by 605
Metadata
- Authors
- Hashimoto, M., Tanabe, Y., Fujii, Y., Kikuta, T., Shibata, H., & Shido, O.
- Affiliations
- Shimane University (JP)
- Corresponding author
- Hashimoto, Michio
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 135
- Issue
- 3
- Pages
- 549-555
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2111757144
- Cited by
- 288
- References
- 46
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 7 · 2016: 20 · 2015: 25 · 2014: 18 · 2013: 13 · 2012: 17
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- docosahexaenoic acid, Alzheimer's disease, amyloid-beta, spatial learning, memory impairment, omega-3 fatty acids, hippocampus, cerebral cortex, oxidative stress, lipid hydroperoxides, antioxidant defense, reference memory, working memory, 8-arm radial maze
- MeSH terms
- Alzheimer Disease, Animals, Cognition, Disease Models, Animal, Docosahexaenoic Acids, Learning, Space Perception, Amyloid beta-Peptides, Rats, Wistar, Reactive Oxygen Species, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review